ArticleOncotarget2014

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.

Jochen J Frietsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.